Cypherpunk Technologies Inc. (CYPH) Leap Therapeutics, Inc. - Shareholder/Analyst Call Prepared Remarks Transcript

Core Points - The company, Cypherpunk Technologies, Inc., formerly known as Leap Therapeutics, Inc., held a virtual Special Meeting of Stockholders on December 15, 2025 [1] - The meeting agenda included several proposals for stockholder approval [2] Proposal Summaries - A proposal to amend the company's Certificate of Incorporation to increase the total number of shares from 250 million to 500 million, with 490 million designated as common stock [3] - A proposal to authorize the Board to amend the Certificate of Incorporation for a reverse stock split at a ratio between 1:5 and 1:20, to be executed at the Board's discretion within one year [4] - A proposal to adopt a new 2025 Equity Incentive Plan [4] - A proposal to allow the company to issue shares exceeding 19.99% of the outstanding common stock to comply with NASDAQ listing rules upon the exercise of certain warrants [5]